Global Protein Therapeutics Market -Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2023

Global Protein Therapeutics Market accounted for $140,109 million in 2016, and is anticipated to reach $217,591 million by 2023, registering a CAGR of 6.5% from 2017 to 2023. Therapeutic protein drugs are an important class of medicines, which are administered to treat an array of different diseases such as cancer, infectious diseases, and others. These drugs hold significant potential to improve human health.

The demand for protein therapeutics has increased considerably, owing to increase in prevalence of chronic diseases and development of plasma-derived therapies. Furthermore, surge in awareness with respect to protein therapeutics among populace boosts the market growth. However, high costs associated with therapeutic proteins and stringent government regulations towards protein therapeutics restrict market growth. Conversely, adoption of protein therapeutics for novel indications and untapped potential of developing countries are anticipated to provide lucrative opportunities to the market players.

The protein therapeutics industry is segmented based product, application, and geography. Depending on product, the market is divided into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone. The applications covered in this study include metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others. Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get Free Sample Report :

North America generated the highest revenue in the protein therapeutics industry in 2016. Asia-Pacific possesses high market potential, owing to increase in awareness about protein therapeutics-based treatments and rise in protein therapeutics applications.

Protein Therapeutics Market Key Segments:

By Product

  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Follicle Stimulating Hormone

By Application

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders,
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Any Enquiry About This Report Visiting :

Show full profile

Basic Member

Reset Password